Compare PubMatic Inc (PUBM) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
PubMatic Inc vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? PubMatic Inc trades at $18.7 (market cap $850.88M), while Royalty Pharma plc Class A Ordinary Shares trades at $56.49 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 29.7× PubMatic Inc's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while PubMatic Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold PubMatic Inc for 40 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| PUBM | RPRX | |
|---|---|---|
Market Cap | $850.88M | $25.27B |
Volume | 997,698 | 3,671,183 |
Sector | Technology | Health |
52-Week High | $19.18 | $63.96 |
52-Week Low | $6.28 | $35.44 |
Typical Hold Time | 40 Days | 0 Days |
Enterprise Value | $754.01M | $32.50B |
Dividend Yield | — | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PubMatic (PUBM) trades at $19.02, up 2.42% with a bullish technical signal and strong analyst consensus. The company shows mixed fundamentals with negative net income margins but positive cash flow and recent earnings beats. Recent Q2 2026 results exceeded expectations with 11% revenue growth, driven by mobile app and CTV segments. Technical indicators show bullish moving averages with neutral oscillators, while support sits at $18 and resistance at $19.
The outlook remains cautiously optimistic with 64.7% analyst buy ratings and a $19.89 price target. Key opportunities include AI-driven ad growth and market share gains, while risks involve persistent profitability challenges and competitive pressures in digital advertising. The CFO's planned retirement adds transitional uncertainty.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About PubMatic Inc
PubMatic Inc is engaged in the digital advertising business. The company provides a specialized cloud infrastructure platform that enables real-time programmatic advertising transactions. The platform helps independent app developers and publishers to control and maximize their digital advertising businesses.
Read more on PUBM →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
